Unrestricted access to sugammadex: Impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs

Anaesthesia and Intensive Care

Volumn 40, Issue 2, 2012, Pages 340-343

  Ledowski, T ^a   Hillyard, S ^a   Kozman, A ^a   Johnston, F ^a,b   Gillies, E ^a,b   Greenaway, M ^a,b   Kyle, B C ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Access; Cost; Sugammadex

Indexed keywords

ATRACURIUM; ATROPINE; GLYCOPYRRONIUM BROMIDE; MIVACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; STEROID; SUGAMMADEX; SUXAMETHONIUM; VECURONIUM;

ADULT; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG ANTAGONISM; DRUG CHOICE; DRUG USE; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; INTUBATION; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MUSCLE RELAXATION; OPERATION DURATION; RETROSPECTIVE STUDY;

EID: 84858957720     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000219     Document Type: Conference Paper

References (6)

1. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120-128.
2. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111:129-140.
3. Puhringer FK, Gordon M, Demeyer I, Sparr HJ, Ingimarsson J, Klarin B et al. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. Br J Anaesth 2010; 105:610-619.
4. Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Hunter JM et al. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment. Br J Anaesth 2010; 105:568-575.
5. Caldwell JE, Miller RD. Clinical implications of sugammadex. Anaesthesia 2009; 64 (Suppl 1):66-72.
6. Taheri PA, Butz DA, Greenfield LJ. Length of stay has minimal impact on the cost of hospital admission. J Am Coll Surg 2000; 191:123-130. (Pubitemid 30622455)